Prognostic significance of DNA content in Stage I adenocarcinoma of the lung

International Journal of Radiation Oncology Biology Physics

Volumn 41, Issue 3, 1998, Pages 573-578

  Roberts, Heidi L ^a   Komaki, Ritsuko ^a   Allen, Pamela ^a   El Naggar, Adel K ^b  

^a Dept Ofradiation Oncol Anderson C ^*  (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Adjuvant treatment; DNA content; Stage I NSCLC

Indexed keywords

DNA;

ADULT; AGED; ARTICLE; BRAIN METASTASIS; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DNA CONTENT; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG RESECTION; LYMPH NODE DISSECTION; MEDIASTINUM LYMPH NODE; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; AGED, 80 AND OVER; ANEUPLOIDY; BRAIN NEOPLASMS; CARCINOMA, NON-SMALL-CELL LUNG; DNA, NEOPLASM; FEMALE; FLOW CYTOMETRY; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; SURVIVAL ANALYSIS; TREATMENT FAILURE;

EID: 0031746353     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(98)00099-6     Document Type: Article

References (28)

1. Mountain C.F., Hermes K.E. Management implications of surgical staging. Muggia F.M., Rozeneweig M. Lung cancer Progress in therapeutic research . 1979;233-242 Raven Press, New York.
2. Komaki R., Fujii T., Perkins P., Ro J.Y., Allen P.K., Mason K.A., Mountain C.F., Milas L. Apoptosis and mitosis as prognostic factors in pathologically staged N1 nonsmall cell lung cancer. Int. J. Radiat. Oncol. Biol. Phys. 36:1996;601-605.
3. Komaki R., Cox J.D., Stark R. Frequency of brain metastasis in adenocarcinoma and large cell carcinoma of the lung Correlation with survival . Int. J. Radiat. Oncol. Biol. Phys. 9:1983;1467-1470.
4. Bunn P.A. Jr, Carney D.N., Gazdar A.F., Whang-Peng J., Matthews M.J. Diagnostic and biological implications of flow cytometric DNA content analysis in lung cancer. Cancer Res. 43:1983;5026-5032.
5. Hedley D.W., Friedlander M.L., Taylor I.W. Method for analysis of cellular DNA content of paraffin-embedded pathological materials using flow cytometry. J. Histochem. Cytochem. 31:1983;1333-1335.
6. McLemore D.D., El-Naggar A.K., Stephens L.C., Jardine J. Modified methodology to improve flow cytometric DNA histograms from paraffin-embedded material. Stain Technol. 65:1990;279-291.
7. Barlogie B., Göhde W., Johnston D.A. Determination of ploidy and proliferative characteristics of human solid tumors by pulse cytophotometry. Cancer Res. 38:1978;3333-3339.
8. Baisch H., Göhde W., Linden W.A. Analysis of PCP-data to determine the fraction of cells in the various phases of cells cycle. Radiat. Environ. Biophys. 12:1975;31-39.
9. Brown B.W., Walker H., Schimeck M., Wright P.R. A life table analysis package for SPSS. Am. Sociol. Rev. 33:1979;225-227.
10. Lee E., Desu M. A computer program for comparing k samples with right-censored data. Computer Prog. Biomed. 2:1972;3115-3121.
11. Pearson K. On the criteria that a given system of deviations from the probability in the case of a correlated system of variable is such that it can be reasonably supposed to have arisen from random sampling. Philosophy. 50:1900;157-175.
12. Merkel D., Dressler L., McGuire W. Flow cytometry, cellular DNA content and prognosis in human malignancy. J. Clin. Oncol. 5:1987;1690-1703.
13. Schmidt R.A., Rusch V.W., Piantadosi S. A flow cytometric study of non-small cancer classified as TIN. Cancer. 69:1992;78-85.
14. Carp N.Z., Ellison D.D., Brophy P. DNA content in correlation with postsurgical stage in non-small cell lung cancer. Ann. Thorac. Surg. 53:1992;680-683.
15. Cibas E.S., Melamed M.R., Zaman M.B., Kimmel M. The effect of tumor size and tumor cell DNA content on the survival of patients with stage I adenocarcinoma of the lung. Cancer. 63:1989;1552-1556.
16. Ojala A., Kallioneimi O.P., Wigren T. Flow cytometric analysis of tumor DNA profile related to response to radiotherapy and survival in inoperable lung cancer. Acta Oncol. 29:1990;983-988.
17. Van Bodegom P.C., Baak J.P.A., Stroet-Van Galen C. The percentage of aneuploid cells is significantly correlated with survival in accurately staged patients with stage I resected squamous cell lung cancer and long-term followup. Cancer. 53:1989;680-683.
18. Ten Velde G.P.M., Schutte B., Vermeulen A., Volovics A., Reynders M.M.J., Blijham G.H. Flow cytometric analysis of DNA ploidy level in paraffin-embedded tissue of nonsmall cell lung cancer. Eur. J. Cancer Clin. Oncol. 24:1988;445-460.
19. Ogawa J., Tsurumi T., Inoue H., Shohtsu A. Relationship between tumor DNA ploidy and regional lymph node changes in lung cancer. Cancer. 69:1992;1688-1695.
20. Salvati F., Teodori L., Gagliardi L., Signora M., Aquilini M., Storniello G. DNA flow cytometric studies of 66 human lung tumors analyzed before treatment prognostic implications . Chest. 96:1989;1092-1098.
21. Zimmerman P.V., Hawson G.A.T., Bint M.H., Parsons P.G. Ploidy as a prognostic determinant in surgically treated lung cancer. Lancet. 2:1987;530-533.
22. Volm M., Drings P., MaRern J., Sonka J. Prognostic significance of DNA patterns and resistance-predictive tests in non-small cell lung carcinoma. Cancer. 56:1985;1396-1403.
23. Volm M., Mattern J., Muller T., Drings P. Flow cytometry of epidermoid lung carcinomas relationship of ploidy and cell cycle phases to survival: a five year follow up study . Anticancer Res. 8:1988;105-112.
24. Rice T., Bauer T., Gephardt G.N. Prognostic significance of cytophotometry in non-small cell lung cancer. J. Thorac. Cardiovasc. Surg. 106:1993;1-17.
25. Isobe H., Miyamoto H., Shimizu T. Prognostic significance of the flow cytometric nuclear DNA content in non-small cell lung cancer. Cancer. 65:1990;1391-1395.
26. Sahin A.A., Ro J.Y., El-Naggar A.K. Flow cytometric analysis of the DNA content of non-small cell lung cancer. Cancer. 65:1990;530-537.
27. Tirendelli-Danesi, D.; Teodori, L.; Mauro, F. Prognostic significance of flow cytometry in lung cancer: a 5-year study. Cancer 983-988; 1990.
28. Tirendelli-Danesi D., Teodori L., Mauro I.C. Prognostic significance of flow cytometry in lung carcinoma A 5-year study . Cancer. 60:1987;844-851.